Pathology Associates international A Company of Science Applications International Corporation An Employoa-Owned Company ARltt-oiH0!

Pathology Review of Reported Tumorigenesis in a Two Year Study of FM-3924 in Rats November 25,1998 BY Pathology Associates International 6217 Centre Park Drive West Chester, Ohio 45069 Telephone (513) 779-9600 Fax (513) 779-9603 003099 Pathology Review of Tumors Reported in Rats Given FM-3924 Introduction: This report presents an independent assessment of tumorigenesis data obtained from a study to determine the chronic toxicity and carcinogenic potential of the fluorochemical FM-3924 in rats.

AR22>-D0% PROTOCOL DETERMINATION OF THE MELTING POINT/MELTING RANGE OF PFOS OECD Guideline for Testing o f Chemicals, 103 Melting Poinl/Melting Range 3M Lab Request No.

Corporate Occupational Medicine 3M Center, Building 220-3W-05 St.

/waa-oMsq C O R N IN G Hazleton MUTAGENICITY TEST ON T-6342 MEASURING CHROMOSOMAL ABERRATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS: WITH A CONFIRMATORY ASSAY WITH MULTIPLE HARVESTS FINAL REPORT AUTHOR Hemalatha Murli, Ph.D.

AR226-2233 Vapor Scavenging Coefficient Estimation Vapor scavenging coefficients are used to estimate the rate of removal of a soluble species that exists below the cloud line based on rain event characteristics, such as intensity and droplet size.

% SPONSOR Elf Atochem S.A.

/ N frU -0 5 2 .5 ACUTE TOXICITY TO FISH TEST SUBSTANCE_______________________________________________ Identity: Perfluorooctanoic acid, ammonium salt; may also be referred to as PFOA ammonium salt, Ammonium perfluorooctanoate, PFO, FC116, FC-126, FC-169, FC-143 or as the major component of FC1015.

<gHQ - oy-06. 373 {oz>o g/l7g,a z ) _________________ ________________________________________________ &o A R Z O fc -a W Analytical Laboratory Report ON THE Determination of the Presence and Concentration of Perfluorooctanesulfonate (PFOS) (CAS Number: 2759-39-3) in the Serum of Sprague-Dawley Rats Exposed to Potassium Perfluorooctanesulfonate via Gavage Laboratory Report No.

AAA6-0679 MULTI-CITY STUDY FINAL FIELD REPORT FOR COLUMBUS GEORGIA AND PORT ST.

/IRlK-O%& 3M MEDICAL DEPARTMENT TOXICOLOGY SERVICES To: Geoijean Adams 290-4-01 cc: John ButenhofF 220-2E-02 From: Marv Case 220-2E-02 Subject: FC 95 and 143 Teratology Date: 26 May 1998 John passed on to me your request for someone to review and write an analysis on the eye lens defect that was reported in the original FC 95 rat teratology study.

'he -` Oeeiei'ie t H i e /jienM iu A < lu. 1 12 b v 1 ; A ' - i-,; bNcvicr Seif net Publishers B V All nnhis reserved <XI()5-27(i<l/9;/S(jyiXl B13ALIP 54011 N 'C ;-- a " ': --p--s A.-,..-*-: -'-I The mechanism underlying the hypolipmie effect of perfluorooctanoic acid (PFOA), perfluorooctane sulphonic acid (PFOSA) and clofibric acid Bente Haughom and 0ystein Spydevold Institute o f Medical Biochemistry, Universi!}

\ CAS Number 307-35-7 4i M _aT7<s Voluntary Use and Exposure Information Profile Perfluorooctanesulfonyl fluoride (POSF) I.

Purpose: AR226-2366 DRAFT *' J-- t> I--V^.

AR226-2418 C-8 SAMPLING FORECAST RCRA CORRECTIVE ACTION PERMIT O VERIFICATION INVESTIGATION (VI) WORK PLAN - FALL 1991 - WHAT IS THE VI ?